Featured posts

Three cancer stocks

Cancer is one of the most interesting areas of work of the ASX’s growing cohort of life sciences companies. Here are three of the fascinating stories emerging..

Full Article >

3 stocks under $20

Here are three stocks poised to smash through the $20 level in share price – in the cases of Orica and Northern Star, heading back above $20.

Full Article >